AzTrials
AzTrials

BurnschestburnNCT05603507

Inspiratory Muscle Training in Children With Chest Burn

A study testing inspiratory muscle training and pulmonary rehabilitation in people with Burns and Respiratory Function Impaired, run by Qassim University at 1 site in Saudi Arabia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

8 weeks of inspiratory muscle training combined with a pulmonary rehabilitation program increases respiratory muscle strength, pulmonary function, functional capacity, and quality of life in chest burned children. Read more about this study

Who is it for?
Ages 10 to 18 years
Conditions the study is for
Burns, Respiratory Function Impaired, Children
What is being tested?
inspiratory muscle training and pulmonary rehabilitation
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
40 participants
Where
1 siteSaudi Arabia
Study dates
10 Sep 2021to 15 May 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Children aged 10 to 18.
  • Following hospital discharge.- Total body surface area (TBSA) of 30% to 50%.
  • Chest burns.
  • Deep partial to full thickness burns.
  • Subjects who had a skin graft or who healed completely were also included.

Who cannot join

  • - Participants who had a nonhealing or open wound.
  • Congenital diaphragmatic hernia.
  • Chest wall deformity.
  • Cardiac or pulmonary problems.

Trial locations and contacts

1 site in 1 country.

Saudi Arabia1 site
  • Outpatient Clinic of College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University

    Al Kharj, Riyadh Region, 11432

Other trials in Saudi Arabia

About this study

Official title: Inspiratory Muscle Training Effects on Pulmonary Function and Quality of Life in Children With Chest Burn

8 weeks of inspiratory muscle training combined with a pulmonary rehabilitation program increases respiratory muscle strength, pulmonary function, functional capacity, and quality of life in chest burned children.

Read the detailed description

The primary purpose of this study is to see how an inspiratory muscle training program along with a pulmonary rehabilitation program improved respiratory muscle strength, respiratory function and quality of life after children with chest burns were discharged from the hospital.

Being tested
inspiratory muscle training, pulmonary rehabilitation
Keywords
chest burn, respiratory muscle strength, lung function
Medical subject headings
Burns, Respiratory Insufficiency

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • inspiratory muscle trainingOther

    Also called inspiratory resistance

    training done with a pressure threshold-loading device

  • pulmonary rehabilitationOther

    Also called Aerobic and resistance training

    Circuit training of aerobic and resistive exercise

Study groups in NCT05603507
Study groupRoleWhat they receive
inspiratory muscle training groupExperimentalreceived both inspiratory muscle training and pulmonary rehabilitation
Receives: Other: inspiratory muscle training; Other: pulmonary rehabilitation
pulmonary rehabilitation groupSham comparatorreceived only pulmonary rehabilitation and sham inspiratory muscle training
Receives: Other: pulmonary rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. maximal inspiratory pressure

    performed using an electronic respiratory pressure meter

    Measured: 1 week after hospital discharge

  2. maximal inspiratory pressure

    performed using an electronic respiratory pressure meter

    Measured: 8 weeks

  3. maximal expiratory pressure

    performed using an electronic respiratory pressure meter

    Measured: 1 week after hospital discharge

  4. maximal expiratory pressure

    performed using an electronic respiratory pressure meter

    Measured: 8 weeks

  5. Pulmonary function test, forced expiratory volume in the first second

    performed using a spirometer, the FEV1 (forced expiratory volume in the first second) was recorded.

    Measured: 1 week after hospital discharge

  6. Pulmonary function test, forced expiratory volume in the first second

    performed using a spirometer, the FEV1 (forced expiratory volume in the first second) was recorded.

    Measured: 8 weeks

  7. Pulmonary function test, forced vital capacity

    performed using a spirometer, the FVC (forced vital capacity) was recorded.

    Measured: 1 week after hospital discharge

  8. Pulmonary function test, forced vital capacity

    performed using a spirometer, the FVC (forced vital capacity) was recorded.

    Measured: 8 weeks

  9. Pulmonary function test, FEV1/FVC ratio

    performed using a spirometer, (forced expiratory volume in the first second/ forced vital capacity) FEV1/FVC ratio was recorded.

    Measured: 1 week after hospital discharge

  10. Pulmonary function test, FEV1/FVC ratio

    performed using a spirometer, (forced expiratory volume in the first second/ forced vital capacity) FEV1/FVC ratio was recorded.

    Measured: 8 weeks

Secondary outcomes (4)
  1. Functional exercise capacity

    assessed using the six-minute walk test

    Measured: 1 week after hospital discharge

  2. Functional exercise capacity

    assessed using the six-minute walk test

    Measured: 8 weeks

  3. Health related Quality of Life

    assessed using the validated cross-culturally adapted version of the Pediatric Quality of life, The Peds-QL is a 23-item scale. Participants scored on a 5-point Likert scale ranging from 0 (never an issue) to 4 (almost always a problem). Following that, the item scores are decoded and linearly transformed to a 100-point scale. The psychosocial functioning summary score and physical functioning summary score were used for this study. A score of 100 indicates the highest functional status, while a score of 0 indicates the lowest functional status.

    Measured: 1 week after hospital discharge

  4. Health related Quality of Life

    assessed using the validated cross-culturally adapted version of the Pediatric Quality of life, The Peds-QL is a 23-item scale. Participants scored on a 5-point Likert scale ranging from 0 (never an issue) to 4 (almost always a problem). Following that, the item scores are decoded and linearly transformed to a 100-point scale. The psychosocial functioning summary score and physical functioning summary score were used for this study. A score of 100 indicates the highest functional status, while a score of 0 indicates the lowest functional status.

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Nov 2022
  2. Study start10 Sep 2021
  3. Primary completion9 Apr 2022
  4. Study completion15 May 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05603507
Sponsor's protocol ID
RHPT/0020/0082
Acronym
chestburn
Status last verified
Oct 2022
First submitted
26 Oct 2022
Last updated
2 Nov 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The data sets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Publications

  • Willis CE, Grisbrook TL, Elliott CM, Wood FM, Wallman KE, Reid SL. Pulmonary function, exercise capacity and physical activity participation in adults following burn. Burns. 2011 Dec;37(8):1326-33. doi: 10.1016/j.burns.2011.03.016. Epub 2011 May 6.

    PubMed 21530086
  • Laszlo G. Standardisation of lung function testing: helpful guidance from the ATS/ERS Task Force. Thorax. 2006 Sep;61(9):744-6. doi: 10.1136/thx.2006.061648.

    PubMed 16936234

Questions about this trial

What is this clinical trial studying?

A study testing inspiratory muscle training and pulmonary rehabilitation in people with Burns and Respiratory Function Impaired, run by Qassim University at 1 site in Saudi Arabia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

maximal inspiratory pressure (time frame: 1 week after hospital discharge). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05603507, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in